Search Results - "Yagnik, Bhrugu"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    EpiMix Based Novel Vaccine Candidate for Shigella: Evidence of Prophylactic Immunity in Balb/c Mice by Padh, Harish, Yagnik, Bhrugu, Sharma, Drashya, Desai, Priti

    “…Multidrug resistant Shigella is one of the leading causes of mortality in children and infants. Availability of vaccine could prevent the Shigella infection…”
    Get full text
    Journal Article
  2. 2

    Dual recombinant Lactococcus lactis for enhanced delivery of DNA vaccine reporter plasmid pPERDBY by Yagnik, Bhrugu, Sharma, Drashya, Padh, Harish, Desai, Priti

    Published in Microbiology and immunology (01-04-2017)
    “…ABSTRACT Food grade Lactococcus lactis has been widely used as an antigen and DNA delivery vehicle. We have previously reported the use of non‐invasive L…”
    Get full text
    Journal Article
  3. 3

    Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure by Berendam, Stella J, Nelson, Ashley N, Yagnik, Bhrugu, Goswami, Ria, Styles, Tiffany M, Neja, Margaret A, Phan, Caroline T, Dankwa, Sedem, Byrd, Alliyah U, Garrido, Carolina, Amara, Rama R, Chahroudi, Ann, Permar, Sallie R, Fouda, Genevieve G

    Published in Frontiers in immunology (13-07-2022)
    “…Early initiation of antiretroviral therapy (ART) significantly improves clinical outcomes and reduces mortality of infants/children living with HIV. However,…”
    Get full text
    Journal Article
  4. 4

    Microbubble-Mediated Enhanced Delivery of Curcumin to Cervical Cancer Cells by Upadhyay, Awaneesh, Yagnik, Bhrugu, Desai, Priti, Dalvi, Sameer V

    Published in ACS omega (31-10-2018)
    “…The major bottleneck in the current chemotherapy treatment of cancer is the low bioavailability and high cytotoxicity. Targeted delivery of drug to the cancer…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Oral immunization with LacVax® OmpA induces protective immune response against Shigella flexneri 2a ATCC 12022 in a murine model by Yagnik, Bhrugu, Sharma, Drashya, Padh, Harish, Desai, Priti

    Published in Vaccine (21-05-2019)
    “…•LacVax® OmpA elicited humoral and cellular immune responses in BALB/c mice.•Oral immunization with LacVax® OmpA elicited sIgA, a hallmark of mucosal…”
    Get full text
    Journal Article
  7. 7

    Immunoinformatic Identification of Potential Epitopes by Desai, Priti, Tarwadi, Divya, Pandya, Bhargav, Yagnik, Bhrugu

    “…Immunoinformatic plays a pivotal role in vaccine design and development. While traditional methods are exclusively depended on immunological experiments, they…”
    Get more information
    Journal Article
  8. 8

    In vivo delivery of pPERDBY to BALB/c mice by LacVax®DNA-I and comparison of elicited immune response with conventional immunization methods by Yagnik, Bhrugu, Sharma, Drashya, Padh, Harish, Desai, Priti

    Published in Gene therapy (01-10-2018)
    “…The non-invasive food grade Lactococcus lactis ( L. lactis ) represents a safe and attractive alternative to invasive pathogens for the delivery of plasmid DNA…”
    Get full text
    Journal Article
  9. 9

    In vivo delivery of pPERDBY to BALB/c mice by LacVax.sup.[R]DNA-I and comparison of elicited immune response with conventional immunization methods by Yagnik, Bhrugu, Sharma, Drashya, Padh, Harish, Desai, Priti

    Published in Gene therapy (01-10-2018)
    “…The non-invasive food grade Lactococcus lactis (L. lactis) represents a safe and attractive alternative to invasive pathogens for the delivery of plasmid DNA…”
    Get full text
    Journal Article
  10. 10

    Construction of a new shuttle vector for DNA delivery into mammalian cells using non-invasive Lactococcus lactis by Yagnik, Bhrugu, Padh, Harish, Desai, Priti

    Published in Microbes and infection (01-04-2016)
    “…Use of food grade Lactococcus lactis (L. lactis) is fast emerging as a safe alternative for delivery of DNA vaccine. To attain efficient DNA delivery, L…”
    Get full text
    Journal Article
  11. 11

    Shigellosis murine model established by intraperitoneal and intranasal route of administration: a comparative comprehension overview by Sharma, Drashya, Yagnik, Bhrugu, Baksi, Ruma, Desai, Nirav, Padh, Harish, Desai, Priti

    Published in Microbes and infection (01-01-2017)
    “…Shigellosis, a major cause of mortality and morbidity, requires development of effective intervention strategy for which animal model mimicking human pathology…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8 + T cells in lymphoid tissue by Rahman, Sheikh Abdul, Yagnik, Bhrugu, Bally, Alexander P, Morrow, Kristen N, Wang, Shelly, Vanderford, Thomas H, Freeman, Gordon J, Ahmed, Rafi, Amara, Rama Rao

    Published in Science immunology (10-09-2021)
    “…During antiretroviral therapy (ART), most of the human immunodeficiency virus (HIV) reservoirs persist in the B cell follicles (BCFs) of lymphoid tissue. Thus,…”
    Get more information
    Journal Article
  15. 15

    Factors Affecting Inducible Expression of Outer Membrane Protein A (OmpA) of Shigella dysenteriae Type-1 in Lactococcus lactis Using Nisin Inducible Controlled Expression (NICE) by Yagnik, Bhrugu, Patel, Shivangi, Dave, Maitree, Sharma, Drashya, Padh, Harish, Desai, Priti

    Published in Indian journal of microbiology (01-03-2016)
    “…Potential use of Lactococcus lactis (L. lactis) as a heterologous protein expression host as well as for delivery of multiple therapeutic proteins has been…”
    Get full text
    Journal Article
  16. 16
  17. 17